Chemical mechanism of the radiation potentiating effects of 2,2-dimethylaziridine-type antitumor agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology*; D001388:Aziridines / Q000494:pharmacology*; D001389:Azirines / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors; D004260:DNA Repair / Q000187:drug effects / Q000528:radiation effects; D006868:Hydrolysis; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D002800:Cholinesterase Inhibitors; D011838:Radiation-Sensitizing Agents; C001181:AB 163; C023504:AB-182